{
  "_meta": {
    "version": "1.2.0",
    "based_on": "factor_classification_v5.json",
    "source": "TF 62차 합의 + M3 확장",
    "last_updated": "2026-01-08",
    "verification_status": "PARTIAL",
    "notes": "fda_designations, crl_resubmission 검증됨. dispute, earnings_call, citizen_petition 추가됨 (검증 필요).",
    "grouping_rules": {
      "fda_designations": "MAX_ONLY (최대값만 적용)",
      "adcom": "EXCLUSIVE (상호 배타적)",
      "crl_resubmission": "INDEPENDENT (독립 적용)",
      "clinical": "INDEPENDENT (독립 적용)",
      "manufacturing": "INDEPENDENT (독립 적용)",
      "dispute": "EXCLUSIVE (상호 배타적)",
      "earnings_call": "INDEPENDENT (독립 적용)",
      "citizen_petition": "EXCLUSIVE (상호 배타적)",
      "special": "INDEPENDENT (독립 적용)"
    }
  },

  "fda_designations": {
    "_group_type": "MAX_ONLY",
    "_group_note": "FDA 지정은 최대값만 적용 (중복 적용 안됨)",
    "breakthrough_therapy": {
      "score": 0.08,
      "classification": "FIXED_BONUS",
      "sample_size": 104,
      "approval_rate": 0.923,
      "source": "FDA CDER BTD Approvals",
      "verification_status": "VERIFIED",
      "confidence": "high"
    },
    "priority_review": {
      "score": 0.05,
      "classification": "FIXED_BONUS",
      "sample_size": 283,
      "approval_rate": 0.901,
      "source": "TF 28차 openFDA",
      "verification_status": "VERIFIED",
      "confidence": "high"
    },
    "fast_track": {
      "score": 0.05,
      "classification": "FIXED_BONUS",
      "sample_size": 90,
      "approval_rate": 0.878,
      "source": "TF 28차 openFDA",
      "verification_status": "VERIFIED",
      "confidence": "high"
    },
    "orphan_drug": {
      "score": 0.04,
      "classification": "FIXED_BONUS",
      "sample_size": 115,
      "approval_rate": 0.896,
      "source": "TF 28차 openFDA",
      "verification_status": "VERIFIED",
      "confidence": "high"
    },
    "accelerated_approval": {
      "score": 0.06,
      "classification": "FIXED_BONUS",
      "sample_size": 36,
      "approval_rate": 0.944,
      "source": "TF 28차 openFDA",
      "verification_status": "VERIFIED",
      "confidence": "medium"
    }
  },

  "adcom": {
    "vote_positive": {
      "score": 0.08,
      "classification": "FIXED_BONUS",
      "condition": "adcom_vote_ratio > 0.5",
      "sample_size": 147,
      "approval_rate": 0.966,
      "source": "JAMA Health Forum 2023 (PMC10329213)",
      "verification_status": "UNKNOWN"
    },
    "vote_negative": {
      "score": -0.20,
      "classification": "FIXED_PENALTY",
      "condition": "0 < adcom_vote_ratio <= 0.5",
      "sample_size": 29,
      "approval_rate": 0.552,
      "source": "TF 62차 Group4",
      "verification_status": "UNKNOWN"
    },
    "waived": {
      "score": 0.04,
      "classification": "FIXED_BONUS",
      "sample_size": 4,
      "approval_rate": 1.0,
      "source": "TF 40차 Bayesian",
      "verification_status": "UNKNOWN"
    }
  },

  "crl_resubmission": {
    "class1_resubmission": {
      "score": 0.09,
      "classification": "FIXED_BONUS",
      "sample_size": 52,
      "approval_rate": 0.885,
      "source": "TF 62차 Group2",
      "verification_status": "UNKNOWN"
    },
    "class2_resubmission": {
      "score": 0.08,
      "classification": "FIXED_BONUS",
      "sample_size": 68,
      "approval_rate": 0.765,
      "source": "TF 62차 Group2",
      "verification_status": "UNKNOWN"
    },
    "new_app_got_crl": {
      "score": -0.20,
      "classification": "FIXED_PENALTY",
      "sample_size": 215,
      "source": "XGBoost v5",
      "verification_status": "UNKNOWN"
    },
    "is_resubmission": {
      "score": -0.091,
      "classification": "FIXED_PENALTY",
      "sample_size": 215,
      "approval_rate": 0.609,
      "source": "전체 재승인률",
      "verification_status": "UNKNOWN"
    },
    "cmc_only": {
      "score": 0.0,
      "classification": "UNCERTAIN",
      "sample_size": 21,
      "approval_rate": 0.810,
      "source": "TF 62차 Group2",
      "notes": "CMC-only는 0%로 중립화 (CDMO 리스크 분리)",
      "verification_status": "UNKNOWN"
    }
  },

  "clinical": {
    "primary_endpoint_not_met": {
      "score": -0.70,
      "classification": "FACT",
      "notes": "Hard Cap 30%. 미달성 = 자동 CRL",
      "verification_status": "UNKNOWN"
    },
    "single_arm_trial": {
      "score": -0.07,
      "classification": "FIXED_PENALTY",
      "sample_size": 37,
      "crl_rate": 0.486,
      "source": "TF 62차 Group1",
      "verification_status": "UNKNOWN"
    },
    "rwe_external_control": {
      "score": -0.15,
      "classification": "FIXED_PENALTY",
      "sample_size": 8,
      "crl_rate": 1.0,
      "source": "TF 62차 Group1",
      "verification_status": "UNKNOWN"
    },
    "trial_region_china_only": {
      "score": -0.50,
      "classification": "FIXED_PENALTY",
      "sample_size": 2,
      "source": "TF 40차",
      "verification_status": "UNKNOWN"
    },
    "clinical_hold_history": {
      "score": -0.08,
      "classification": "FIXED_PENALTY",
      "sample_size": 16,
      "source": "내부 데이터",
      "verification_status": "UNKNOWN"
    }
  },

  "manufacturing": {
    "facility_pai_passed": {
      "score": 0.12,
      "classification": "FIXED_BONUS",
      "source": "SEC 8-K",
      "verification_status": "UNKNOWN"
    },
    "facility_warning_letter": {
      "score": -0.30,
      "classification": "FIXED_PENALTY",
      "source": "FDA Warning Letters DB",
      "verification_status": "UNKNOWN"
    },
    "fda_483_critical": {
      "score": -0.10,
      "classification": "FIXED_PENALTY",
      "condition": "observations >= 10",
      "source": "TF 62차 Group3",
      "verification_status": "UNKNOWN"
    },
    "fda_483_moderate": {
      "score": -0.10,
      "classification": "FIXED_PENALTY",
      "condition": "4 <= observations <= 9",
      "source": "TF 62차 Group3",
      "verification_status": "UNKNOWN"
    },
    "fda_483_minor": {
      "score": -0.05,
      "classification": "FIXED_PENALTY",
      "condition": "1 <= observations <= 3",
      "source": "TF 62차 Group3",
      "verification_status": "UNKNOWN"
    },
    "cdmo_high_risk": {
      "score": -0.08,
      "classification": "FIXED_PENALTY",
      "high_risk_cdmos": ["Zydus Lifesciences", "Intas Pharmaceuticals", "Jubilant Pharma"],
      "source": "TF 62차 Group2",
      "verification_status": "UNKNOWN"
    }
  },

  "special": {
    "first_in_class": {
      "score": 0.05,
      "classification": "FACT",
      "sample_size": 10,
      "approval_rate": 1.0,
      "source": "Dataset v7",
      "verification_status": "UNKNOWN"
    },
    "supplement": {
      "score": 0.05,
      "classification": "FACT",
      "sample_size": 85,
      "approval_rate": 0.929,
      "source": "Dataset v7",
      "verification_status": "UNKNOWN"
    },
    "spa_agreed": {
      "score": 0.08,
      "classification": "FIXED_BONUS",
      "sample_size": 3,
      "approval_rate": 0.88,
      "source": "FDA Guidance",
      "verification_status": "UNKNOWN"
    },
    "spa_rescinded": {
      "score": -0.30,
      "classification": "FIXED_PENALTY",
      "sample_size": 1,
      "source": "OTLK 사례",
      "verification_status": "UNKNOWN"
    }
  },

  "dispute": {
    "_group_type": "EXCLUSIVE",
    "_group_note": "FDA 분쟁 결과 (상호 배타적)",
    "dispute_won_fully": {
      "score": 0.10,
      "classification": "FIXED_BONUS",
      "sample_size": 5,
      "source": "FDA CDRH Disputes",
      "notes": "분쟁에서 완전 승리",
      "verification_status": "NEEDS_VERIFICATION"
    },
    "dispute_partial": {
      "score": -0.05,
      "classification": "FIXED_PENALTY",
      "sample_size": 3,
      "source": "FDA CDRH Disputes",
      "notes": "분쟁에서 부분 승리/패배",
      "verification_status": "NEEDS_VERIFICATION"
    },
    "dispute_lost_fully": {
      "score": -0.20,
      "classification": "FIXED_PENALTY",
      "sample_size": 2,
      "source": "FDA CDRH Disputes",
      "notes": "분쟁에서 완전 패배",
      "verification_status": "NEEDS_VERIFICATION"
    }
  },

  "earnings_call": {
    "_group_type": "INDEPENDENT",
    "_group_note": "어닝콜 시그널 (독립 적용)",
    "label_negotiation": {
      "score": 0.08,
      "classification": "FIXED_BONUS",
      "sample_size": 12,
      "source": "SEC 8-K / Earnings Transcripts",
      "notes": "경영진이 라벨 협상 진행 중 언급",
      "verification_status": "NEEDS_VERIFICATION"
    },
    "timeline_delayed": {
      "score": -0.10,
      "classification": "FIXED_PENALTY",
      "sample_size": 8,
      "source": "SEC 8-K / Earnings Transcripts",
      "notes": "경영진이 타임라인 지연 암시",
      "verification_status": "NEEDS_VERIFICATION"
    },
    "management_confident": {
      "score": 0.05,
      "classification": "FIXED_BONUS",
      "sample_size": 15,
      "source": "Earnings Transcripts",
      "notes": "경영진이 승인에 강한 자신감 표명",
      "verification_status": "NEEDS_VERIFICATION"
    },
    "management_cautious": {
      "score": -0.05,
      "classification": "FIXED_PENALTY",
      "sample_size": 10,
      "source": "Earnings Transcripts",
      "notes": "경영진이 불확실성 강조",
      "verification_status": "NEEDS_VERIFICATION"
    }
  },

  "citizen_petition": {
    "_group_type": "EXCLUSIVE",
    "_group_note": "시민 청원 (상호 배타적)",
    "petition_filed": {
      "score": -0.08,
      "classification": "FIXED_PENALTY",
      "sample_size": 25,
      "source": "FDA Dockets",
      "notes": "시민 청원 제출됨 (결과 불명)",
      "verification_status": "NEEDS_VERIFICATION"
    },
    "petition_denied": {
      "score": 0.05,
      "classification": "FIXED_BONUS",
      "sample_size": 18,
      "source": "FDA Dockets",
      "notes": "FDA가 시민 청원 기각",
      "verification_status": "NEEDS_VERIFICATION"
    },
    "petition_granted": {
      "score": -0.25,
      "classification": "FIXED_PENALTY",
      "sample_size": 3,
      "source": "FDA Dockets",
      "notes": "FDA가 시민 청원 수용",
      "verification_status": "NEEDS_VERIFICATION"
    }
  }
}
